Investigational COVID-19 Convalescent Plasma

Updated August 24, 2020: The FDA authorized an Emergency Use Authorization (EUA) for distribution of COVID-19 convalescent plasma (CCP) and administration, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in hospitalized patients.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in